Covetrus Inc (CVET) Forecast, Price Target & Analyst Ratings
NASDAQ:CVET • US22304C1009
20.99 USD
+0.06 (+0.29%)
At close: Oct 12, 2022
20.99 USD
0 (0%)
After Hours: 10/12/2022, 8:10:14 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Covetrus Inc (CVET).
Forecast Snapshot
Consensus Price Target
$21.76
+ 3.67% Upside
Next Earnings Forecast
Release DateNov 3, 2022
PeriodQ3 / 2022
EPS Estimate$0.27
Revenue Estimate1.266B
ChartMill Buy Consensus
50.91%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$21.76
Upside
+ 3.67%
From current price of $20.99 to mean target of $21.76, Based on 11 analyst forecasts
Low
$21.21
Median
$21.42
High
$23.10
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for CVET. The average price target is 21.76 USD. This implies a price increase of 3.67% is expected in the next year compared to the current price of 20.99.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.91%
CVET was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about CVET.
In the previous month the buy percentage consensus was at a similar level.
CVET was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-06-13 | Stifel | Downgrade | Buy -> Hold |
| 2022-05-26 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-05-25 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-05-23 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-05-23 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-19 | Goldman Sachs | Maintains | Sell |
| 2022-05-09 | Barclays | Maintains | Overweight |
| 2022-05-06 | Raymond James | Maintains | Outperform |
| 2021-11-18 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-11-05 | Raymond James | Maintains | Outperform |
| 2021-08-09 | Barclays | Maintains | Overweight |
| 2021-08-06 | Raymond James | Maintains | Outperform |
| 2021-07-12 | Guggenheim | Upgrade | Neutral -> Buy |
| 2021-03-02 | Raymond James | Maintains | Outperform |
| 2021-02-17 | Barclays | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 3, 2022
PeriodQ3 / 2022
EPS Estimate$0.27
Revenue Estimate1.266B
Revenue Q2Q8.95%
EPS Q2Q20.36%
Number of Analysts8
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
CVET is expected to report earnings on 11/3/2022. The consensus EPS estimate for the next earnings is 0.27 USD and the consensus revenue estimate is 1.27B USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.976B 5.24% | 4.339B 9.13% | 4.575B 5.44% | 4.884B 6.74% | 5.18B 6.07% | 5.511B 6.39% | 5.739B 4.15% | 6.097B 6.23% | |
| EBITDA YoY % growth | 96M -54.22% | 97M 1.04% | 148M 52.58% | 278.439M 88.13% | 317.247M 13.94% | 334.982M 5.59% | 360.48M 7.61% | 395.678M 9.76% | |
| EBIT YoY % growth | -59M -140.52% | -69M -16.95% | -23M 66.67% | 242.433M 1,154.06% | 281.649M 16.18% | 298.262M 5.90% | 324.689M 8.86% | 360.525M 11.04% | |
| Operating Margin | -1.48% | -1.59% | -0.50% | 4.96% | 5.44% | 5.41% | 5.66% | 5.91% | |
| EPS YoY % growth | 0.61 7.75% | 0.92 50.82% | 0.96 3.91% | 1.12 16.83% | 1.30 15.98% | 1.41 8.66% | 1.55 10.12% | 1.74 12.32% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.27 20.36% | 0.29 9.72% | 0.28 11.79% | 0.30 21.18% | 0.33 21.03% | 0.34 20.86% |
| Revenue Q2Q % growth | 1.266B 8.95% | 1.242B 10.74% | 1.234B 7.49% | 1.317B 8.19% | 1.332B 5.24% | 1.32B 6.21% |
| EBITDA Q2Q % growth | 72.217M -41.76% | 75.554M -53.93% | 74.154M 61.20% | 81.498M -4.12% | 81.396M 12.71% | 87.618M 15.97% |
| EBIT Q2Q % growth | 56.662M 1,516.54% | 60.616M 965.95% | 58.381M 873.01% | 69.045M 1,626.12% | 72.726M 28.35% | 78.846M 30.07% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
13.76%
EPS Next 5 Year
12.74%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.57%
Revenue Next 5 Year
5.42%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Covetrus Inc / CVET Forecast FAQ
What do analysts expect the price target to be for Covetrus Inc (CVET)?
11 analysts have analysed CVET and the average price target is 21.76 USD. This implies a price increase of 3.67% is expected in the next year compared to the current price of 20.99.
What is the next earnings date for CVET stock?
Covetrus Inc (CVET) will report earnings on 2022-11-03, after the market close.
What are the consensus estimates for CVET stock next earnings?
The consensus EPS estimate for the next earnings of Covetrus Inc (CVET) is 0.27 USD and the consensus revenue estimate is 1.27B USD.
What is the expected long term growth rate for CVET stock?
The expected long term growth rate for Covetrus Inc (CVET) is 5.57%.